Grove Bank & Trust’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16K Sell
45
-6
-12% -$1.93K ﹤0.01% 601
2026
Q2
$24.6K Sell
51
-75
-60% -$19.9K ﹤0.01% 534
2026
Q1
$13.8K Sell
126
-1
-0.8% -$142 ﹤0.01% 584
2025
Q4
$21.1K Sell
127
-221
-64% -$37K ﹤0.01% 539
2025
Q3
$68.1K Buy
+348
New +$57.2K 0.01% 380

Other funds holding ALAB

Grove Bank & Trust's ALAB Position: Q3 2026 in Review

Grove Bank & Trust reduced its Astera Labs (ALAB) stake by 12% in Q3 2026, selling an estimated $1.93K and leaving 45 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Grove Bank & Trust first reported a position in ALAB in Q3 2025 and has held it in 5 quarters since. The position peaked at $68.1K in Q3 2025. 27 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Grove Bank & Trust held 45 shares of Astera Labs worth $16K as of Q3 2026.
  • Grove Bank & Trust sold 6 Astera Labs shares in Q3 2026, an estimated $1.93K.
  • Astera Labs made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #601 holding.
  • Grove Bank & Trust first reported a position in Astera Labs in Q3 2025 and has held it in 5 quarters since.
  • Grove Bank & Trust's Astera Labs position peaked at $68.1K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.